Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
Bo InnoHealth is a spin-off from the Hong Kong Polytechnic University developing a novel microencapsulation technology which can protect probiotics and probiotics and enable their use in a wider range of applications such as snacks, hot drinks and pet food. The company’s approach is based on using mushroom cells as a protective material to make […]
Talus Bio aims to revolutionize drug development for gene regulators by enabling the ability to study gene regulatory proteins (GRPs) in a living cell environment. The company’s initial focus is on small-molecule drug development in oncology. Founded in 2020 as a spin out of the University of Washington and Altius Institute for Biomedical Sciences, the […]
Founded in 2020, iTolerance is regenerative medicine company developing a potential cure for Type 1 Diabetes that eliminates the need for chronic immunosuppression of patients. The company’s lead program, ITOL-101, is an adjunct therapy with pancreatic islet cell implant currently in development for the treatment of or as a potential breakthrough cure for Type 1 […]